Professor Sir Stephen O’Rahilly
Meet Stephen, a co-investigator on CANCAN
Stephen O’Rahilly’s research has been concerned with the elucidation of the fundamental mechanisms underlying obesity, insulin resistance and Type 2 diabetes and the translation of those discoveries into improvements in patient care. His work has uncovered several previously unrecognised genetic causes of these diseases including some that are amenable to specific treatments. He graduated in Medicine from University College Dublin in 1981.
More about Stephen
From 1982 to 1991 he undertook postgraduate clinical and research training in general medicine, diabetes and endocrinology in London, Oxford and Harvard. In 1991 he obtained a Wellcome Trust Senior Clinical Fellowship and established his laboratory at the University of Cambridge where he now holds Chair of Clinical Biochemistry and Medicine, Co-Director of the Wellcome-MRC Institute of Metabolic Science (IMS) (the establishment of which he led) and Director of the MRC Metabolic Diseases Unit. He is also Scientific Director, NIHR Cambridge Biomedical Research Centre and Honorary Consultant Physician at Addenbrooke’s Hospital.
He has won many awards including the Heinrich Wieland Prize, the Inbev Baillet Latour Prize, the Zülch Prize, the European Hormone Medal, the first EASD/Novo Nordisk Foundation Diabetes Prize for Excellence, the Banting Medal for Scientific Achievement, the Manpei Suzuki Prize and the Royal Society Croonian Medal. He was appointed Knight Bachelor in 2013.